Abstract:Ferroptosis, a novel form of regulated cell death (RCD), has garnered increasing attention in studies on numerous human diseases in the last decade. Emerging evidence has indicated that the pathological process of ferroptosis involves the overloaded production of reactive oxygen species (ROS), followed by aberrant accumulation of lipid peroxidation in an iron-dependent manner, accompanied with an increased uptake of polyunsaturated fatty acids into the cellular membrane, further unfolding an ancient vulnerability in multiple context. The unique nature of ferroptosis differentiates it from other forms of RCD, as it is intricately associated with several biological processes, including the metabolism of iron, amino acids, synthesis of ROS and lipid peroxidation. Accordingly, inducers and inhibitors designed to target the key processes of ferroptosis have been extensively studied. Characterized by its distinct properties as mentioned above and its inducible nature, ferroptosis has been widely implicated in several diseases, and numerous studies have focused on identifying effective therapeutic targets for multiple human diseases, including in cancer, by targeting this process. In the present review, recent studies on the involvement of ferroptosis in several types of cancer are summarized and the findings discussed, highlighting the need for increased contemplation of its involvement in the study of cancer, particularly in the clinical setting. A comprehensive summary of the biological mechanisms underlying ferroptosis, the implications of the multiple inducers of ferroptosis, as well as immunotherapy targeting ferroptosis in different types of cancer is provided in this review to highlight the pathophysiological role of ferroptosis in carcinogenesis, to serve as an aid in future studies on the role of ferroptosis in cancer.

Ferroptosis: A Critical Moderator in the Life Cycle of Immune Cells

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis in Tumor Immunity and Therapy

Ferroptosis: a double-edged sword mediating immune tolerance of cancer

Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?

Ferroptosis: Iron-mediated cell death linked to disease pathogenesis

Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation

Ferroptosis in life: To be or not to be

When ferroptosis meets pathogenic infections

Ferroptosis in Antitumor Therapy: Unraveling Regulatory Mechanisms and Immunogenic Potential

Ferroptosis: principles and significance in health and disease

Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy

Effect of ferroptosis on infectious, inflammatory, and immune diseases is receiving attention: visualization and bibliometric analysis (Preprint)

Ferroptosis in cancer (Review)

Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity

Ferroptosis-mediated immune responses in cancer

Ferroptosis interaction with inflammatory microenvironments: Mechanism, biology, and treatment

Ferroptosis: A double-edged sword

Ferroptosis Biology and Implication in Cancers

Ferroptosis contributes to immunosuppression

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.